Skip to main content
OpenTrials

Clinical trial condition

Skin Diseases

Explore clinical trials studying Skin Diseases. Study availability and eligibility vary by location and protocol.

23,025 public trials 3,714 recruiting studies
Refine in advanced search Browse all conditions

Skin Diseases trial results

Recruiting

Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib

NCT06855498

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Hidradenitis, +9 more
Locations
  • Investigative Site US106 Birmingham, Alabama, United States
  • Investigative Site US086 Birmingham, Alabama, United States
  • Investigative Site US098 Montgomery, Alabama, United States
  • Investigative Site US004 Phoenix, Arizona, United States
View all 318 locations
View Trial Details
Recruiting

Pharmacokinetics, Safety, and Efficacy of Povorcitinib in Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa

NCT07213973

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Hidradenitis, +9 more
Locations
  • University of Alabama At Birmingham Birmingham, Alabama, United States
  • Medical Dermatology Specialists Phoenix Phoenix, Arizona, United States
  • Saguaro Dermatology Phoenix, Arizona, United States
  • Uconn Health Farmington, Connecticut, United States
View all 30 locations
View Trial Details
Recruiting

Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread

NCT06324357

Conditions
Adenocarcinoma Of Esophagus, Breast Diseases, Breast Neoplasms, +18 more
Locations
  • The Oncology Institute of Hope and Innovation Cerritos, California, United States
  • Ellison Medical Institute Los Angeles, California, United States
  • Valkyrie Clinical Trials Los Angeles, California, United States
  • University of California Los Angeles Los Angeles, California, United States
View all 105 locations
View Trial Details
Recruiting

Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects

NCT05232916

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +8 more
Locations
  • Southern Cancer Center Mobile, Alabama, United States
  • City of Hope - Cancer Center Phoenix Goodyear, Arizona, United States
  • Tucson Medical Center HealthCare Tucson, Arizona, United States
  • City of Hope - Duarte Cancer Center Duarte, California, United States
View all 179 locations
View Trial Details
Recruiting

A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation

NCT05877599

Conditions
Adnexal Diseases, Breast Cancer, Breast Diseases, +47 more
Locations
  • Research Site Gilbert, Arizona, United States
  • Research Site Duarte, California, United States
  • Research Site Newport Beach, California, United States
  • Research Site Santa Monica, California, United States
View all 18 locations
View Trial Details
Recruiting

Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer

NCT05386108

Conditions
Brain Diseases, Brain Neoplasms, Breast Diseases, +9 more
Locations
  • Providence Medical Foundation Fullerton, California, United States
  • California Research Institute Los Angeles, California, United States
  • Carle Cancer Center Urbana, Illinois, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View all 86 locations
View Trial Details

Related conditions